Skip to main content
UTHR logo

UTHR · UNITED THERAPEUTICS Corp · Analyst Estimates

Track UTHR — free
$542.00 +60.53 (+12.57%) At close · Sep 30
Market Cap
$20.39B
Shares
42.89M
Volume · Sep 30 3.34M Avg daily vol (3M) 552.76K

Analyst Estimates

Compare analyst forecasts for UNITED THERAPEUTICS Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-25 06:52 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
22.65367
26.0681
29.05
—
26.0418
26.91867
26.0418
27.31271
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
7
1
6
0
Revenue
USD
Publication date not stated
3047000000
3140958770
3208800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
19.07
28.58195
36.1
—
28.69286
31.5121
28.69286
31.62049
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
11
1
2
0
Revenue
USD
Publication date not stated
2799000000
3432402490
4000000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.4
6.4587
7.63
—
6.43859
7.0005
6.43859
7.12948
— — — —
EPS
analysts
Publication date not stated
— — —
13
— — — —
7
1
4
0
Revenue
USD
Publication date not stated
751000000
786261820
813000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.05408
6.70346
8.35
—
6.70875
7.04826
6.70875
7.08132
— — — —
EPS
analysts
Publication date not stated
— — —
13
— — — —
6
1
6
0
Revenue
USD
Publication date not stated
732000000
791448970
831000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1082554 CUSIP 91307C102 13F (30d) 21 filings 17 filers Visit website Investor relations